HBV genotype B patients have more serum and intrahepatic HBsAg decline following interferon therapy than genotype C patients

臺大醫院-內科部;臺大醫院-病理部;臺大醫學院-微生物學科暨研究所;臺大醫學院-臨床醫學研究所;Su, Tung-HungTung-HungSuLiu, Chun-JenChun-JenLiuYang, Hung-ChihHung-ChihYangCheng, Huei-RuHuei-RuChengJeng, Yung-MingYung-MingJengLiu, Chen-HuaChen-HuaLiuTseng, Tai-ChungTai-ChungTsengChen, Chi-LingChi-LingChenChen, Pei-JerPei-JerChenChen, Ding-ShinnDing-ShinnChenKao, Jia-HorngJia-HorngKao2014-02-142018-07-062014-02-142018-07-062012http://ntur.lib.ntu.edu.tw//handle/246246/25896682 bytestext/htmlHBV genotype B patients have more serum and intrahepatic HBsAg decline following interferon therapy than genotype C patientshttp://ntur.lib.ntu.edu.tw/bitstream/246246/258966/1/index.html